Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Guang-Wei Feng, Zhong-Fang Wang, Peng He, Qin-Ying Lan, Ling Ni, Ya-Zheng Yang, Chen-Fei Wang, Ting-Ting Cui, Li-Li Huang, Yong-Qiang Yan, Zhi-Wei Jiang, Qing Yang, Bang-Wei Yu, Xi Han, Jing-Jing Chen, Shu-Yuan Yang, Lin Yuan, Ling-Yun Zhou, Ge Liu, Ke Li, Zhen Huang, Jin-Cun Zhao, Zhong-Yu Hu & Zhi-Qiang Xie. (2023) Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trial. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Abid H. Banday, Salika Jeelani & Victor J. Hruby. (2015) Cancer vaccine adjuvants – recent clinical progress and future perspectives. Immunopharmacology and Immunotoxicology 37:1, pages 1-11.
Read now
Read now
Lorenzo Galluzzi, Erika Vacchelli, Alexander Eggermont, Wolf Hervé Fridman, Jérôme Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel & Guido Kroemer. (2012) Trial Watch. OncoImmunology 1:5, pages 699-739.
Read now
Read now
Emanuele Montomoli, Simona Piccirella, Baharak Khadang, Elisa Mennitto, Roberto Camerini & Alfonso De Rosa. (2011) Current adjuvants and new perspectives in vaccine formulation. Expert Review of Vaccines 10:7, pages 1053-1061.
Read now
Read now
Curtis Cooper & David Mackie. (2011) Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV™ safety and efficacy. Expert Review of Vaccines 10:4, pages 417-427.
Read now
Read now
Jiří Beran, Lenka Hobzova, Veronika Wertzova, Sherine Kuriyakose, Maarten Leyssen, Murielle Surquin & Sophie Houard. (2010) Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults. Human Vaccines 6:7, pages 578-584.
Read now
Read now
Thomas Meyer & Eggert Stockfleth. (2008) Clinical investigations of Toll-like receptor agonists. Expert Opinion on Investigational Drugs 17:7, pages 1051-1065.
Read now
Read now
Articles from other publishers (45)
Sivakumar S. Moni, Siddig Ibrahim Abdelwahab, Aamena Jabeen, Mohamed Eltaib Elmobark, Duaa Aqaili, Gassem Ghoal, Bassem Oraibi, Abdulla Mohammed Farasani, Ahmed Ali Jerah, Mahdi Mohammed A. Alnajai & Abdul Majeed Hamad Mohammad Alowayni. (2023) Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations. Vaccines 11:11, pages 1704.
Crossref
Crossref
Tingmei Zhao, Yulong Cai, Yujie Jiang, Xuemei He, Yuquan Wei, Yifan Yu & Xiaohe Tian. (2023) Vaccine adjuvants: mechanisms and platforms. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Yidan Qiao, Yikang Zhan, Yongli Zhang, Jieyi Deng, Achun Chen, Bingfeng Liu, Yiwen Zhang, Ting Pan, Wangjian Zhang, Hui Zhang & Xin He. (2022) Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses. Frontiers in Immunology 13.
Crossref
Crossref
Lilit Grigoryan, Audrey Lee, Alexandra C. Walls, Lilin Lai, Benjamin Franco, Prabhu S. Arunachalam, Yupeng Feng, Wei Luo, Abigail Vanderheiden, Katharine Floyd, Samuel Wrenn, Deleah Pettie, Marcos C. Miranda, Elizabeth Kepl, Rashmi Ravichandran, Claire Sydeman, Natalie Brunette, Michael Murphy, Brooke Fiala, Lauren Carter, Robert L. Coffman, David Novack, Harry Kleanthous, Derek T. O’Hagan, Robbert van der Most, Jason S. McLellan, Mehul Suthar, David Veesler, Neil P. King & Bali Pulendran. (2022) Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice. npj Vaccines 7:1.
Crossref
Crossref
Alessio Facciolà, Giuseppa Visalli, Antonio Laganà & Angela Di Pietro. (2022) An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives. Vaccines 10:5, pages 819.
Crossref
Crossref
Dipyaman GangulyDipyaman Ganguly. 2022. Plasmacytoid Dendritic Cells. Plasmacytoid Dendritic Cells
147
160
.
Guang Han Ong, Benedict Shi Xiang Lian, Takumi Kawasaki & Taro Kawai. (2021) Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Bali Pulendran, Prabhu S. Arunachalam & Derek T. O’Hagan. (2021) Emerging concepts in the science of vaccine adjuvants. Nature Reviews Drug Discovery 20:6, pages 454-475.
Crossref
Crossref
Guillaume Clavé, Maeva Reverte, Jean-Jacques Vasseur & Michael Smietana. (2021) Modified internucleoside linkages for nuclease-resistant oligonucleotides. RSC Chemical Biology 2:1, pages 94-150.
Crossref
Crossref
Peter Richmond, Lara Hatchuel, Min Dong, Brenda Ma, Branda Hu, Igor Smolenov, Ping Li, Peng Liang, Htay Htay Han, Joshua Liang & Ralf Clemens. (2021) Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial. The Lancet 397:10275, pages 682-694.
Crossref
Crossref
Juan E Corral, Joshua Y Kwon, Freddy Caldera, Surakit Pungpapong, Aaron C Spaulding, Bijan J Borah, James P Moriarty & Francis A Farraye. (2021) Cost-Effectiveness of an Adjuvanted Hepatitis B Vaccine (HEPLISAV-B) in Patients With Inflammatory Bowel Disease. Crohn's & Colitis 360 3:1.
Crossref
Crossref
Ritwik Patra, Nabarun Chandra Das & Suprabhat Mukherjee. 2021. Coronavirus Therapeutics – Volume I. Coronavirus Therapeutics – Volume I
87
109
.
Kara-Lee Aves, Louise Goksøyr & Adam F. Sander. (2020) Advantages and Prospects of Tag/Catcher Mediated Antigen Display on Capsid-Like Particle-Based Vaccines. Viruses 12:2, pages 185.
Crossref
Crossref
Sakineh Pirahmadi, Sedigheh Zakeri, Akram A. Mehrizi, Navid D. Djadid, Abbas-Ali Raz, Jafar J. Sani, Ronak Abbasi & Zahra Ghorbanzadeh. (2019) Cell-traversal protein for ookinetes and sporozoites (CelTOS) formulated with potent TLR adjuvants induces high-affinity antibodies that inhibit Plasmodium falciparum infection in Anopheles stephensi. Malaria Journal 18:1.
Crossref
Crossref
Stephen N. Crooke, Inna G. Ovsyannikova, Gregory A. Poland & Richard B. Kennedy. (2019) Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses. Experimental Gerontology 124, pages 110632.
Crossref
Crossref
Sakineh Pirahmadi, Sedigheh Zakeri, Akram A. Mehrizi, Navid D. Djadid, Abbas-Ali Raz & Jafar J. Sani. (2019) Combining Monophosphoryl Lipid A (MPL), CpG Oligodeoxynucleotide (ODN), and QS-21 Adjuvants Induces Strong and Persistent Functional Antibodies and T Cell Responses against Cell-Traversal Protein for Ookinetes and Sporozoites (CelTOS) of Plasmodium falciparum in BALB/c Mice. Infection and Immunity 87:6.
Crossref
Crossref
Juliana de Souza Apostólico, Victória Alves Santos Lunardelli, Marcio Massao Yamamoto, Edecio Cunha-Neto, Silvia Beatriz Boscardin & Daniela Santoro Rosa. (2019) Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope Vaccine. Frontiers in Immunology 10.
Crossref
Crossref
Jennifer A. Whitaker, Kenneth Valles, Pritish K. Tosh & Gregory A. Poland. 2019. Vaccinations. Vaccinations
139
162
.
Zhiyong Ma, Qian Cao, Yong Xiong, Ejuan Zhang & Mengji Lu. (2018) Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B. Vaccines 6:1, pages 6.
Crossref
Crossref
Shilpa Ray & Mrutyunjay Suar. 2018. Biomedical Engineering. Biomedical Engineering
1353
1401
.
Lydia A. Haile, Montserrat Puig, Swamy K. Polumuri, Jill Ascher & Daniela Verthelyi. (2017) In Vivo Effect of Innate Immune Response Modulating Impurities on the Skin Milieu Using a Macaque Model: Impact on Product Immunogenicity. Journal of Pharmaceutical Sciences 106:3, pages 751-760.
Crossref
Crossref
John D. Campbell. 2017. Vaccine Adjuvants. Vaccine Adjuvants
15
27
.
Juliana de Souza Apostólico, Victória Alves Santos Lunardelli, Fernanda Caroline Coirada, Silvia Beatriz Boscardin & Daniela Santoro Rosa. (2016)
Adjuvants: Classification,
Modus Operandi
, and Licensing
. Journal of Immunology Research 2016, pages 1-16.
Crossref
Crossref
Manasi Majumdar, R.K. Ratho, Yogesh Chawla & Mini P. Singh. (2015) Role of TLR gene expression and cytokine profiling in the immunopathogenesis of viral hepatitis E. Journal of Clinical Virology 73, pages 8-13.
Crossref
Crossref
Zhiyong Ma, Ejuan Zhang, Dongliang Yang & Mengji Lu. (2014) Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses. Cellular & Molecular Immunology 12:3, pages 273-282.
Crossref
Crossref
Steven BlackEnnio De GregorioRino Rappuoli. (2015) Developing vaccines for an aging population. Science Translational Medicine 7:281.
Crossref
Crossref
Shilpa Ray & Mrutyunjay Suar. 2015. Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering. Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering
221
268
.
Vivek K. Sharma, Raman K. Sharma & Sunil K. Singh. (2014) Antisense oligonucleotides: modifications and clinical trials. Med. Chem. Commun. 5:10, pages 1454-1471.
Crossref
Crossref
Franziska Zabel, Thomas M. Kündig & Martin F. Bachmann. (2013) Virus-induced humoral immunity: on how B cell responses are initiated. Current Opinion in Virology 3:3, pages 357-362.
Crossref
Crossref
Julie Todoroff, Muriel M. Lemaire, Catherine Fillee, Fabienne Jurion, Jean-Christophe Renauld, Kris Huygen & Rita Vanbever. (2013) Mucosal and Systemic Immune Responses to Mycobacterium tuberculosis Antigen 85A following Its Co-Delivery with CpG, MPLA or LTB to the Lungs in Mice. PLoS ONE 8:5, pages e63344.
Crossref
Crossref
Adnan Nasir & Anthony Gaspari. 2013. Nanotechnology in Dermatology. Nanotechnology in Dermatology
151
164
.
Sarah F. Schillie, Philip R. Spradling & Trudy V. Murphy. (2012) Immune Response of Hepatitis B Vaccine Among Persons With Diabetes. Diabetes Care 35:12, pages 2690-2697.
Crossref
Crossref
Vijayakumar Gosu, Shaherin Basith, O-Pil Kwon & Sangdun Choi. (2012) Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling. Molecules 17:11, pages 13503-13529.
Crossref
Crossref
Wai-Kay Seto, James Fung, Man-Fung Yuen & Ching-Lung Lai. (2012) Future Prevention and Treatment of Chronic Hepatitis B Infection. Journal of Clinical Gastroenterology 46:9, pages 725-734.
Crossref
Crossref
Chasity D. Andrews, Myung-Sook Huh, Kathryn Patton, Debbie Higgins, Gary Van Nest, Gary Ott & Kyung-Dall Lee. (2012) Encapsulating Immunostimulatory CpG Oligonucleotides in Listeriolysin O-Liposomes Promotes a Th1-Type Response and CTL Activity. Molecular Pharmaceutics 9:5, pages 1118-1125.
Crossref
Crossref
Stuart M. Levitz & Douglas T. Golenbock. (2012) Beyond Empiricism: Informing Vaccine Development through Innate Immunity Research. Cell 148:6, pages 1284-1292.
Crossref
Crossref
Ruth Broering, Mengji Lu & Joerg F. Schlaak. (2011) Role of Toll-like receptors in liver health and disease. Clinical Science 121:10, pages 415-426.
Crossref
Crossref
Daniel C. Freed, Victoria M. Towne, Danilo R. Casimiro, Qinjian Zhao & Tong-Ming Fu. (2011) Evaluating functional antibodies in rhesus monkeys immunized with hepatitis B virus surface antigen vaccine with novel adjuvant formulations. Vaccine 29:50, pages 9385-9390.
Crossref
Crossref
Gerd Lipowsky & Martin F. Bachmann. 2011. Development of Vaccines. Development of Vaccines
19
63
.
M Lamine Mbow, Ennio De Gregorio, Nicholas M Valiante & Rino Rappuoli. (2010) New adjuvants for human vaccines. Current Opinion in Immunology 22:3, pages 411-416.
Crossref
Crossref
Elizabeth J. Hennessy, Andrew E. Parker & Luke A. J. O'Neill. (2010) Targeting Toll-like receptors: emerging therapeutics?. Nature Reviews Drug Discovery 9:4, pages 293-307.
Crossref
Crossref
Daan Crommelin, Pieter Stolk, Luc Besançon, Vinod Shah, Kamal Midha & Hubert Leufkens. (2010) Pharmaceutical sciences in 2020. Nature Reviews Drug Discovery 9:2, pages 99-100.
Crossref
Crossref
Stanley A. Plotkin. (2009) Vaccines: the Fourth Century. Clinical and Vaccine Immunology 16:12, pages 1709-1719.
Crossref
Crossref
KyungDong Bae, JunYoul Choi, YangSuk Jang, SangJeom Ahn & ByungKi Hur. (2009) Innovative vaccine production technologies: The evolution and value of vaccine production technologies. Archives of Pharmacal Research 32:4, pages 465-480.
Crossref
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:6.
Crossref
Crossref